Schedule 13D ownership disclosure
Janux Therapeutics Inc
Security class unavailable · CUSIP: 47103J105
Event date: 2024-03-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,593,395
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-031587
- Form type
- SC 13D
- Filer
- Janux Therapeutics, Inc.
- CIK
- CIK 1817713
- Filed
- Mar 06, 2024
- Reporting period
- Mar 04, 2024
- Description
- Schedule 13D beneficial ownership